The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.

Celltrion expands European sales of new biosimilars

Oct 30, 2026 02:55 (12h ago)

Verifying

Celltrion is accelerating European sales expansion for its new biosimilar lineup.
Omlyclo and Aptozma are rapidly entering local markets through Celltrion's direct sales system.
Celltrion made the statement on the 30th regarding its high-margin products.